Slideshow
Author(s):
Three new studies from Obesity Week 2018 offered highlights of different surgical interventions for obese patients.
Tirzepatide Could Replace Daily Hormone Shots for Rare Genetic Fat Disorder
Diabetes Dialogue: Understanding Semaglutide (Ozempic) in CKD and T2D
FDA News Month in Review: January 2025
Diabetes Dialogue: ADA’s 2025 Standards of Care in Diabetes Therapeutics
Enobosarm Protects Lean Mass in Topline Phase 2b Trial Results
Thyroid Cancer Diagnoses Rise in First Year of GLP-1 RA Use